- Rank in Search Criteria: 1551
World Rank (Aug-2026): 3,681
Market Cap (Aug-2026): 4.921 Billion USD
World Rank (Jan-05-2024): 3,458
Market Cap (Jan-05-2024): 4.06 Billion USD
Annual Revenue in USD: 1,246 Million USD
Annual Net Income in USD: 593 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: It is commercial bank with headquarters in Vietnam.
- Rank in Search Criteria: 1552
World Rank (Aug-2026): 3,683
Market Cap (Aug-2026): 4.915 Billion USD
World Rank (Jan-05-2024): 2,458
Market Cap (Jan-05-2024): 6.24 Billion USD
World Rank (Jul-30-2023): 2963
Market Cap (Jul-30-2023): 5.02 Billion USD
World Rank (Jan-2022): 2,773
Market Cap (Jan-2022): 6.17 Billion USDAnnual Revenue in USD: 504 Million USD
Annual Operating Income in USD: 145 Million USD
Annual Net Income in USD: 190 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: SK Biopharmaceuticals is a Biopharmaceutical company that develops new drugs in support of innovations in the medical field. The headquarters is in South Korea.
- Rank in Search Criteria: 1553
World Rank (Aug-2026): 3,684
Market Cap (Aug-2026): 4.913 Billion USD
World Rank (Jan-05-2024): 4,061
Market Cap (Jan-05-2024): 3.31 Billion USD
Annual Revenue in USD: 618 Million USD
Annual Net Income in USD: 171 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: Gulf Bank K.S.C.P is a banking and financial services company with headquarters in Kuwait.
- Rank in Search Criteria: 1554
World Rank (Aug-2026): 3,685
Market Cap (Aug-2026): 4.913 Billion USD
World Rank (Jan-05-2024): 6,946
Market Cap (Jan-05-2024): 1.44 Billion USD
World Rank (Jul-30-2023): 6295
Market Cap (Jul-30-2023): 1.73 Billion USD
World Rank (Jan-2022): 5,914
Market Cap (Jan-2022): 2.20 Billion USDHeadquarters Country: China Annual Revenue in USD: 304 Million USD
Annual Operating Income in USD: 43 Million USD
Annual Net Income in USD: 32 Million USD
Annual Results for Period ending: For year ending December-2025
- Rank in Search Criteria: 1555
World Rank (Aug-2026): 3,686
Market Cap (Aug-2026): 4.910 Billion USD
World Rank (Jan-05-2024): 3,196
Market Cap (Jan-05-2024): 4.49 Billion USD
World Rank (Jul-30-2023): 2987
Market Cap (Jul-30-2023): 4.97 Billion USD
World Rank (Jan-2022): 2,869
Market Cap (Jan-2022): 5.91 Billion USDHeadquarters Country: China Annual Revenue in USD: 636 Million USD
Annual Net Income in USD: 341 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: Manufacture computers, desktops, printers, networking equipment and develops software products. Headquarters is in Shenzhen, China.
- Rank in Search Criteria: 1556
World Rank (Aug-2026): 3,687
Market Cap (Aug-2026): 4.908 Billion USD
World Rank (Jan-05-2024): 5,743
Market Cap (Jan-05-2024): 1.97 Billion USD
World Rank (Jul-30-2023): 4399
Market Cap (Jul-30-2023): 2.96 Billion USD
World Rank (Jan-2022): 5,155
Market Cap (Jan-2022): 2.76 Billion USDHeadquarters Country: China Annual Revenue in USD: 1,730 Million USD
Annual Operating Income in USD: 80 Million USD
Annual Net Income in USD: 30 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: GUANGZHOU GREAT POWER ENERGY AND TECHNOLOGY CO. LTD is a high tech enterprise company focusing on manufacturing, researching and developing lithium batteries. The headquarters is in China.
- Rank in Search Criteria: 1557
World Rank (Aug-2026): 3,690
Market Cap (Aug-2026): 4.896 Billion USD
World Rank (Jan-05-2024): 3,008
Market Cap (Jan-05-2024): 4.83 Billion USD
World Rank (Jul-30-2023): 2973
Market Cap (Jul-30-2023): 5.00 Billion USD
World Rank (Jan-2022): 2,456
Market Cap (Jan-2022): 7.22 Billion USDHeadquarters Country: China Annual Revenue in USD: 362 Million USD
Annual Operating Income in USD: -134 Million USD
Annual Net Income in USD: -122 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 1,357
Employee Count as of Date: As on 2020
Company Profile: Shanghai Junshi Biosciences is an Innovation Driven Biopharmaceutical company. The company annual revenue is 111 million USD and 1,357 employee as on 2020. The headquarters is in China.
- Rank in Search Criteria: 1558
World Rank (Aug-2026): 3,691
Market Cap (Aug-2026): 4.895 Billion USD
World Rank (Jan-05-2024): 7,087
Market Cap (Jan-05-2024): 1.40 Billion USD
World Rank (Jul-30-2023): 7608
Market Cap (Jul-30-2023): 1.26 Billion USD
World Rank (Jan-2022): 9,292
Market Cap (Jan-2022): 1.02 Billion USDHeadquarters Country: China Annual Revenue in USD: 549 Million USD
Annual Operating Income in USD: -8 Million USD
Annual Net Income in USD: -11 Million USD
Annual Results for Period ending: For year ending December-2025
- Rank in Search Criteria: 1559
World Rank (Aug-2026): 3,692
Market Cap (Aug-2026): 4.892 Billion USD
World Rank (Jan-05-2024): 3,539
Market Cap (Jan-05-2024): 3.96 Billion USD
World Rank (Jul-30-2023): 3307
Market Cap (Jul-30-2023): 4.41 Billion USD
World Rank (Jan-2022): 2,899
Market Cap (Jan-2022): 5.85 Billion USDHeadquarters Country: China Annual Revenue in USD: 491 Million USD
Annual Net Income in USD: 151 Million USD
Annual Results for Period ending: For year ending December-2025
- Rank in Search Criteria: 1560
World Rank (Aug-2026): 3,697
Market Cap (Aug-2026): 4.874 Billion USD
World Rank (Jan-05-2024): 2,529
Market Cap (Jan-05-2024): 6.03 Billion USD
World Rank (Jul-30-2023): 2252
Market Cap (Jul-30-2023): 6.91 Billion USD
World Rank (Jan-2022): 1,991
Market Cap (Jan-2022): 9.34 Billion USDAnnual Revenue in USD: 1,278 Million USD
Annual Operating Income in USD: 756 Million USD
Annual Net Income in USD: 232 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 4,104
Employee Count as of Date: As on 2022
Company Profile: Real Estate and Property Investment company with headquarters is in Hong Kong.